|drug3193||Study D Wiki||1.00|
|drug3191||Study B Wiki||1.00|
|drug3192||Study C Wiki||1.00|
There is one clinical trial.
Coronaviruses are enveloped viruses with an RNA genome. Carrageenans are sulfate polysaccharides synthesized by red algae. Studies conducted in adults and children with the common cold showed the effectiveness of the use of Carrageenan in nasal spray. For decades, the antiviral action of Carrageenans has been described in numerous studies with different viruses that infect humans: herpes viruses types 1 and 2, human immunodeficiency virus, human papillomavirus, H1N1 influenza virus, dengue virus, rhinovirus, hepatitis A virus, and enteroviruses. Studies on the dynamics of COVID-19 disease show an intense and rapid pharyngeal multiplication in the first 3-5 days of the onset of symptoms, prior to the onset of pulmonary disease. Finally, this molecule has shown a viricidal effect against SARS-Cov2 in vitro. All this underscores the potential value of a therapy that inhibits the virus in the rhinopharynx.
Description: COVID 19 disease will be defined for clinical diagnose and positive Polymerase Chain Reaction testMeasure: diagnose of COVID19 disease Time: 28 days
Description: number of subjects who develop severe COVID19 diseaseMeasure: Progression to a more severe disease state, defined as need for oxygen therapy. Time: 28 days
Description: number of days with clinical symptomsMeasure: lasting of disease Time: 28 days
Description: number of subjects who develop the disease within one week after finishing treatmentMeasure: Incidence of COVID-19 disease onset in the first week after treatment Time: 1 week after finishing treatment
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports